The BRAF-inhibitor PLX4720 inhibits CXCL8 secretion in BRAFV600E mutated and normal thyroid cells: a further anti-cancer effect of BRAF-inhibitors

F. Coperchini; L. Croce; M. Denegri; O. Awwad; S.T. Ngnitejeu; M. Muzza; V. Capelli; F. Latrofa; L. Persani; L. Chiovato; M. Rotondi

doi:10.1038/s41598-019-40818-w

The BRAF-inhibitor PLX4720 inhibits CXCL8 secretion in BRAFV600E mutated and normal thyroid cells: a further anti-cancer effect of BRAF-inhibitors

F. Coperchini, L. Croce, M. Denegri, O. Awwad, S.T. Ngnitejeu, M. Muzza, V. Capelli, F. Latrofa, L. Persani, L. Chiovato, M. Rotondi

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Scientific Reports
Volume	9
Issue number	1
DOIs	https://doi.org/10.1038/s41598-019-40818-w
Publication status	Published - 2019

Access to Document

10.1038/s41598-019-40818-w

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062829402&doi=10.1038%2fs41598-019-40818-w&partnerID=40&md5=5bfe348dd53d1b2af10dde065c13d187

Cite this

Coperchini, F., Croce, L., Denegri, M., Awwad, O., Ngnitejeu, S. T., Muzza, M., Capelli, V., Latrofa, F., Persani, L., Chiovato, L., & Rotondi, M. (2019). The BRAF-inhibitor PLX4720 inhibits CXCL8 secretion in BRAFV600E mutated and normal thyroid cells: a further anti-cancer effect of BRAF-inhibitors. Scientific Reports, 9(1). https://doi.org/10.1038/s41598-019-40818-w

@article{bd245c7340c04305beef086dad91054f,

title = "The BRAF-inhibitor PLX4720 inhibits CXCL8 secretion in BRAFV600E mutated and normal thyroid cells: a further anti-cancer effect of BRAF-inhibitors",

author = "F. Coperchini and L. Croce and M. Denegri and O. Awwad and S.T. Ngnitejeu and M. Muzza and V. Capelli and F. Latrofa and L. Persani and L. Chiovato and M. Rotondi",

note = "Cited By :4 Export Date: 17 February 2020",

year = "2019",

doi = "10.1038/s41598-019-40818-w",

language = "English",

volume = "9",

journal = "Scientific Reports",

issn = "2045-2322",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - The BRAF-inhibitor PLX4720 inhibits CXCL8 secretion in BRAFV600E mutated and normal thyroid cells: a further anti-cancer effect of BRAF-inhibitors

AU - Coperchini, F.

AU - Croce, L.

AU - Denegri, M.

AU - Awwad, O.

AU - Ngnitejeu, S.T.

AU - Muzza, M.

AU - Capelli, V.

AU - Latrofa, F.

AU - Persani, L.

AU - Chiovato, L.

AU - Rotondi, M.

N1 - Cited By :4 Export Date: 17 February 2020

PY - 2019

Y1 - 2019

U2 - 10.1038/s41598-019-40818-w

DO - 10.1038/s41598-019-40818-w

M3 - Article

SN - 2045-2322

VL - 9

JO - Scientific Reports

JF - Scientific Reports

IS - 1

ER -